Atlas Trials

Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease

Clinical trial NCT02370524 · COMPLETED

Trial details

NCT number
NCT02370524
Sponsor
Molecular NeuroImaging
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease (AD)
Start date
2015-01-01
Primary completion
2016-01-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.